News

Filter

Current filters:

AB ScienceOncology

AB Science files pancreatic cancer candidate masitinib with EMA

17-10-2012

France-based AB Science SA (NYSE Euronext - FR0010557264 - AB) has confirmed the filing of a Marketing…

AB ScienceEuropemasitinibOncologyPharmaceuticalRegulation

AB Science leaps as GIST candidate masitinib beats Sutent

06-02-2012

France-based AB Science (AB: EN Paris) saw its share price rocket as much as 72% to 10.60 euros after…

AB ScienceGastro-intestinalsmasitinibOncologyPfizerPharmaceuticalResearchSutent

COMPANY SPOTLIGHT

Menarini

Back to top